Your browser doesn't support javascript.
loading
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.
Adotévi, Olivier; Vernerey, Dewi; Jacoulet, Pascale; Meurisse, Aurélia; Laheurte, Caroline; Almotlak, Hamadi; Jacquin, Marion; Kaulek, Vincent; Boullerot, Laura; Malfroy, Marine; Orillard, Emeline; Eberst, Guillaume; Lagrange, Aurélie; Favier, Laure; Gainet-Brun, Marie; Doucet, Ludovic; Teixeira, Luis; Ghrieb, Zineb; Clairet, Anne-Laure; Guillaume, Yves; Kroemer, Marie; Hocquet, Didier; Moltenis, Mélanie; Limat, Samuel; Quoix, Elisabeth; Mascaux, Céline; Debieuvre, Didier; Fagnoni-Legat, Christine; Borg, Christophe; Westeel, Virginie.
Afiliación
  • Adotévi O; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.
  • Vernerey D; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
  • Jacoulet P; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
  • Meurisse A; Department of Medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France.
  • Laheurte C; Department of Pneumology, University Hospital of Besançon, Besançon, France.
  • Almotlak H; Department of Medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, Besançon, France.
  • Jacquin M; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
  • Kaulek V; EFS Bourgogne Franche-Comté, UMR1098, Plateforme de Biomonitoring, Besançon, France.
  • Boullerot L; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.
  • Malfroy M; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France.
  • Orillard E; Department of Pneumology, University Hospital of Besançon, Besançon, France.
  • Eberst G; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
  • Lagrange A; EFS Bourgogne Franche-Comté, UMR1098, Plateforme de Biomonitoring, Besançon, France.
  • Favier L; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, University Hospital of Besançon, Besançon, France.
  • Gainet-Brun M; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
  • Doucet L; Department of Medical Oncology, University Hospital of Besançon, Besançon, France.
  • Teixeira L; Department of Pneumology, University Hospital of Besançon, Besançon, France.
  • Ghrieb Z; INSERM, EFS BFC, UMR1098, RIGHT, University of Bourgogne Franche-Comté, Besançon, France.
  • Clairet AL; Department of Pneumology, University Hospital of Besançon, Besançon, France.
  • Guillaume Y; Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, Dijon, France.
  • Kroemer M; Department of Medical Oncology, Georges François Leclerc Cancer Center-UNICANCER, Dijon, France.
  • Hocquet D; Department of Pneumology, University Hospital of Besançon, Besançon, France.
  • Moltenis M; Department of Medical Oncology, AP-HP Hôpital Saint Louis, Paris, France.
  • Limat S; Department of Medical Oncology, AP-HP Hôpital Saint Louis, Paris, France.
  • Quoix E; INSERM CIC 1427, Centre d'Investigations Cliniques, Université de Paris Cité, AP-HP Hôpital Saint-Louis, Paris, France.
  • Mascaux C; Department of Pharmacy, University Hospital of Besançon, Besançon, France.
  • Debieuvre D; Department of Pharmacy, University Hospital of Besançon, Besançon, France.
  • Fagnoni-Legat C; Department of Pharmacy, University Hospital of Besançon, Besançon, France.
  • Borg C; Hygiène Hospitalière, Centre Hospitalier Universitaire, Besançon, France.
  • Westeel V; Vigilance Unit, Department of Clinical Research and Innovation, University Hospital of Besançon, Besançon, France.
J Clin Oncol ; 41(2): 373-384, 2023 01 10.
Article en En | MEDLINE | ID: mdl-36070539

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Vacunas contra el Cáncer / Inmunogenicidad Vacunal / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Vacunas contra el Cáncer / Inmunogenicidad Vacunal / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article País de afiliación: Francia